These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21148024)

  • 1. Gender differences in brain serotonin transporter availability in panic disorder.
    Maron E; Tõru I; Hirvonen J; Tuominen L; Lumme V; Vasar V; Shlik J; Nutt DJ; Helin S; Någren K; Tiihonen J; Hietala J
    J Psychopharmacol; 2011 Jul; 25(7):952-9. PubMed ID: 21148024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender-specific abnormalities in the serotonin transporter system in panic disorder.
    Cannon DM; Klaver JM; Klug SA; Carlson PJ; Luckenbaugh DA; Ichise M; Drevets WC
    Int J Neuropsychopharmacol; 2013 May; 16(4):733-43. PubMed ID: 22953744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET.
    Jovanovic H; Lundberg J; Karlsson P; Cerin A; Saijo T; Varrone A; Halldin C; Nordström AL
    Neuroimage; 2008 Feb; 39(3):1408-19. PubMed ID: 18036835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin transporter in attention-deficit hyperactivity disorder--preliminary results from a positron emission tomography study.
    Karlsson L; Tuominen L; Huotarinen A; Leppämäki S; Sihvola E; Helin S; Sipilä M; Tani P; Hirvonen J; Hietala J; Karlsson H
    Psychiatry Res; 2013 May; 212(2):164-5. PubMed ID: 23566552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems.
    Schain M; Tóth M; Cselényi Z; Stenkrona P; Halldin C; Farde L; Varrone A
    Neuroimage; 2012 Mar; 60(1):800-7. PubMed ID: 22227138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disproportionate Reduction of Serotonin Transporter May Predict the Response and Adherence to Antidepressants in Patients with Major Depressive Disorder: A Positron Emission Tomography Study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Kuo SC; Chen CY; Liang CS; Yen CH; Huang CC; Ma KH; Shiue CY; Huang WS; Shyu JF; Wan FJ; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2015 Jan; 18(7):pyu120. PubMed ID: 25568284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic neurotransmission in the living human brain: a positron emission tomography study using [¹¹C]dasb and [¹¹C]WAY100635 in young healthy men.
    Takano H; Ito H; Takahashi H; Arakawa R; Okumura M; Kodaka F; Otsuka T; Kato M; Suhara T
    Synapse; 2011 Jul; 65(7):624-33. PubMed ID: 21484882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positron emission tomography imaging of the serotonin transporter and 5-HT(1A) receptor in alcohol dependence.
    Martinez D; Slifstein M; Gil R; Hwang DR; Huang Y; Perez A; Frankle WG; Laruelle M; Krystal J; Abi-Dargham A
    Biol Psychiatry; 2009 Jan; 65(2):175-80. PubMed ID: 18962444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonality-resilient individuals downregulate their cerebral 5-HT transporter binding in winter - A longitudinal combined
    Mc Mahon B; Nørgaard M; Svarer C; Andersen SB; Madsen MK; Baaré WFC; Madsen J; Frokjaer VG; Knudsen GM
    Eur Neuropsychopharmacol; 2018 Oct; 28(10):1151-1160. PubMed ID: 30077433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperament, character and serotonin activity in the human brain: a positron emission tomography study based on a general population cohort.
    Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Cloninger CR; Raitakari O; Hietala J; Keltikangas-Järvinen L
    Psychol Med; 2013 Apr; 43(4):881-94. PubMed ID: 22850434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suicidal ideation modulates the reduction in serotonin transporter availability in male military conscripts with major depression: A 4-[18F]-ADAM PET study.
    Yeh YW; Ho PS; Chen CY; Kuo SC; Liang CS; Yen CH; Huang CC; Shiue CY; Huang WS; Ma KH; Lu RB; Huang SY
    World J Biol Psychiatry; 2015 Oct; 16(7):502-12. PubMed ID: 26068129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered serotonin transporter binding potential in patients with obsessive-compulsive disorder under escitalopram treatment: [11C]DASB PET study.
    Kim E; Howes OD; Park JW; Kim SN; Shin SA; Kim BH; Turkheimer FE; Lee YS; Kwon JS
    Psychol Med; 2016 Jan; 46(2):357-66. PubMed ID: 26423910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radiometabolite study of the serotonin transporter PET radioligand [(11)C]MADAM.
    Gourand F; Emond P; Bergström JP; Takano A; Gulyás B; Guilloteau D; Barré L; Halldin C
    Nucl Med Biol; 2014 Jul; 41(6):501-6. PubMed ID: 24857865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral serotonin transporter binding is inversely related to body mass index.
    Erritzoe D; Frokjaer VG; Haahr MT; Kalbitzer J; Svarer C; Holst KK; Hansen DL; Jernigan TL; Lehel S; Knudsen GM
    Neuroimage; 2010 Aug; 52(1):284-9. PubMed ID: 20382236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans.
    Talbot PS; Frankle WG; Hwang DR; Huang Y; Suckow RF; Slifstein M; Abi-Dargham A; Laruelle M
    Synapse; 2005 Mar; 55(3):164-75. PubMed ID: 15605360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression.
    Hahn A; Haeusler D; Kraus C; Höflich AS; Kranz GS; Baldinger P; Savli M; Mitterhauser M; Wadsak W; Karanikas G; Kasper S; Lanzenberger R
    Hum Brain Mapp; 2014 Aug; 35(8):3857-66. PubMed ID: 24443158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced serotonin type 1A receptor binding in panic disorder.
    Neumeister A; Bain E; Nugent AC; Carson RE; Bonne O; Luckenbaugh DA; Eckelman W; Herscovitch P; Charney DS; Drevets WC
    J Neurosci; 2004 Jan; 24(3):589-91. PubMed ID: 14736842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serotonin transporter availability in untreated early-onset and late-onset patients with obsessive-compulsive disorder.
    Hesse S; Stengler K; Regenthal R; Patt M; Becker GA; Franke A; Knüpfer H; Meyer PM; Luthardt J; Jahn I; Lobsien D; Heinke W; Brust P; Hegerl U; Sabri O
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):606-17. PubMed ID: 21232166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling?
    Buchert R; Thiele F; Thomasius R; Wilke F; Petersen K; Brenner W; Mester J; Spies L; Clausen M
    J Psychopharmacol; 2007 Aug; 21(6):628-34. PubMed ID: 17092972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incongruent reduction of serotonin transporter associated with suicide attempts in patients with major depressive disorder: a positron emission tomography study with 4-[18F]-ADAM.
    Yeh YW; Ho PS; Chen CY; Kuo SC; Liang CS; Ma KH; Shiue CY; Huang WS; Cheng CY; Wang TY; Lu RB; Huang SY
    Int J Neuropsychopharmacol; 2014 Oct; 18(3):. PubMed ID: 25522405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.